Global Cancer Targeted Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Cancer Targeted Therapy Market Overview

• 1.1 Product Overview and Scope of Cancer Targeted Therapy
• 1.2 Classification of Cancer Targeted Therapy by Types
  • 1.2.1 Global Cancer Targeted Therapy Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Cancer Targeted Therapy Revenue Market Share by Types in 2018
  • 1.2.3 Tumor Antigens As Targets of Antibodies
  • 1.2.4 Development of Antibodies for Clinical Purposes
  • 1.2.5 Complement Dependent Cytotoxicity (CDC)
  • 1.2.6 Signal Transduction Changes
• 1.3 Global Cancer Targeted Therapy Market by Application
  • 1.3.1 Global Cancer Targeted Therapy Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Cancer Targeted Therapy Market by Regions
  • 1.4.1 Global Cancer Targeted Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Cancer Targeted Therapy Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Targeted Therapy Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Targeted Therapy Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Cancer Targeted Therapy Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Targeted Therapy Status and Prospect (2014-2024)
• 1.5 Global Market Size of Cancer Targeted Therapy (2014-2024)

2 Manufacturers Profiles

• 2.1 Advaxis
  • 2.1.1 Business Overview
  • 2.1.2 Cancer Targeted Therapy Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Advaxis Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Bind Therapeutics
  • 2.2.1 Business Overview
  • 2.2.2 Cancer Targeted Therapy Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Bind Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Boehringer Ingelheim
  • 2.3.1 Business Overview
  • 2.3.2 Cancer Targeted Therapy Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Boehringer Ingelheim Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bristol Mayer Squibb
  • 2.4.1 Business Overview
  • 2.4.2 Cancer Targeted Therapy Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bristol Mayer Squibb Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Celldex Therapeutics
  • 2.5.1 Business Overview
  • 2.5.2 Cancer Targeted Therapy Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Celldex Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Dendreon Corporation
  • 2.6.1 Business Overview
  • 2.6.2 Cancer Targeted Therapy Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Dendreon Corporation Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Eli Lily
  • 2.7.1 Business Overview
  • 2.7.2 Cancer Targeted Therapy Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Eli Lily Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 GalaxoSmithKline
  • 2.8.1 Business Overview
  • 2.8.2 Cancer Targeted Therapy Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 GalaxoSmithKline Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Galena Biopharma
  • 2.9.1 Business Overview
  • 2.9.2 Cancer Targeted Therapy Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Galena Biopharma Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Genetech
  • 2.10.1 Business Overview
  • 2.10.2 Cancer Targeted Therapy Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Genetech Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 ImmunoCellular Therapeutics
  • 2.11.1 Business Overview
  • 2.11.2 Cancer Targeted Therapy Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 ImmunoCellular Therapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 ImmunoGen
  • 2.12.1 Business Overview
  • 2.12.2 Cancer Targeted Therapy Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 ImmunoGen Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Inovio Pharmaceuticals
  • 2.13.1 Business Overview
  • 2.13.2 Cancer Targeted Therapy Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Inovio Pharmaceuticals Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Johnson & Johnson
  • 2.14.1 Business Overview
  • 2.14.2 Cancer Targeted Therapy Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Johnson & Johnson Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 NeoStem Oncology
  • 2.15.1 Business Overview
  • 2.15.2 Cancer Targeted Therapy Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 NeoStem Oncology Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 NewLink Genetics
  • 2.16.1 Business Overview
  • 2.16.2 Cancer Targeted Therapy Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 NewLink Genetics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Northwest Biotherapeutics
  • 2.17.1 Business Overview
  • 2.17.2 Cancer Targeted Therapy Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Northwest Biotherapeutics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Merck
  • 2.18.1 Business Overview
  • 2.18.2 Cancer Targeted Therapy Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Merck Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.19 Novartis
  • 2.19.1 Business Overview
  • 2.19.2 Cancer Targeted Therapy Type and Applications
    • 2.19.2.1 Product A
    • 2.19.2.2 Product B
  • 2.19.3 Novartis Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.20 Peregrine Pharmaceuticals
  • 2.20.1 Business Overview
  • 2.20.2 Cancer Targeted Therapy Type and Applications
    • 2.20.2.1 Product A
    • 2.20.2.2 Product B
  • 2.20.3 Peregrine Pharmaceuticals Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.21 Pfizer
  • 2.21.1 Business Overview
  • 2.2.2 Cancer Targeted Therapy Type and Applications
    • 2.21.2.1 Product A
    • 2.21.2.2 Product B
  • 2.21.3 Pfizer Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.22 Roche
  • 2.22.1 Business Overview
  • 2.22.2 Cancer Targeted Therapy Type and Applications
    • 2.22.2.1 Product A
    • 2.22.2.2 Product B
  • 2.22.3 Roche Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.23 Sanofi
  • 2.23.1 Business Overview
  • 2.23.2 Cancer Targeted Therapy Type and Applications
    • 2.23.2.1 Product A
    • 2.23.2.2 Product B
  • 2.23.3 Sanofi Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.24 Seattle Genetics
  • 2.24.1 Business Overview
  • 2.24.2 Cancer Targeted Therapy Type and Applications
    • 2.24.2.1 Product A
    • 2.24.2.2 Product B
  • 2.24.3 Seattle Genetics Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.25 Teva
  • 2.25.1 Business Overview
  • 2.25.2 Cancer Targeted Therapy Type and Applications
    • 2.25.2.1 Product A
    • 2.25.2.2 Product B
  • 2.25.3 Teva Cancer Targeted Therapy Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cancer Targeted Therapy Market Competition, by Players

• 3.1 Global Cancer Targeted Therapy Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Cancer Targeted Therapy Players Market Share
  • 3.2.2 Top 10 Cancer Targeted Therapy Players Market Share
• 3.3 Market Competition Trend

4 Global Cancer Targeted Therapy Market Size by Regions

• 4.1 Global Cancer Targeted Therapy Revenue and Market Share by Regions
• 4.2 North America Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 4.3 Europe Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 4.5 South America Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)

5 North America Cancer Targeted Therapy Revenue by Countries

• 5.1 North America Cancer Targeted Therapy Revenue by Countries (2014-2019)
• 5.2 USA Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 5.3 Canada Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)

6 Europe Cancer Targeted Therapy Revenue by Countries

• 6.1 Europe Cancer Targeted Therapy Revenue by Countries (2014-2019)
• 6.2 Germany Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 6.3 UK Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 6.4 France Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 6.5 Russia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 6.6 Italy Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Cancer Targeted Therapy Revenue by Countries

• 7.1 Asia-Pacific Cancer Targeted Therapy Revenue by Countries (2014-2019)
• 7.2 China Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 7.3 Japan Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 7.4 Korea Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 7.5 India Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)

8 South America Cancer Targeted Therapy Revenue by Countries

• 8.1 South America Cancer Targeted Therapy Revenue by Countries (2014-2019)
• 8.2 Brazil Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Cancer Targeted Therapy by Countries

• 9.1 Middle East and Africa Cancer Targeted Therapy Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 9.3 UAE Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Cancer Targeted Therapy Revenue and Growth Rate (2014-2019)

10 Global Cancer Targeted Therapy Market Segment by Type

• 10.1 Global Cancer Targeted Therapy Revenue and Market Share by Type (2014-2019)
• 10.2 Global Cancer Targeted Therapy Market Forecast by Type (2019-2024)
• 10.3 Tumor Antigens As Targets of Antibodies Revenue Growth Rate (2014-2024)
• 10.4 Development of Antibodies for Clinical Purposes Revenue Growth Rate (2014-2024)
• 10.5 Complement Dependent Cytotoxicity (CDC) Revenue Growth Rate (2014-2024)
• 10.6 Signal Transduction Changes Revenue Growth Rate (2014-2024)

11 Global Cancer Targeted Therapy Market Segment by Application

• 11.1 Global Cancer Targeted Therapy Revenue Market Share by Application (2014-2019)
• 11.2 Cancer Targeted Therapy Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Clinic Revenue Growth (2014-2019)
• 11.5 Other Revenue Growth (2014-2019)

12 Global Cancer Targeted Therapy Market Size Forecast (2019-2024)

• 12.1 Global Cancer Targeted Therapy Market Size Forecast (2019-2024)
• 12.2 Global Cancer Targeted Therapy Market Forecast by Regions (2019-2024)
• 12.3 North America Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
• 12.4 Europe Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
• 12.6 South America Cancer Targeted Therapy Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Cancer Targeted Therapy Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology